| Adjuvant pembrolizumab versus placebo in resected stage III melanoma AMM Eggermont, CU Blank, M Mandala, GV Long, V Atkinson, S Dalle, ... New England Journal of Medicine 378 (19), 1789-1801, 2018 | 2167 | 2018 |
| Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet G Argenziano, HP Soyer, S Chimenti, R Talamini, R Corona, F Sera, ... Journal of the American Academy of Dermatology 48 (5), 679-693, 2003 | 1697 | 2003 |
| Human–computer collaboration for skin cancer recognition P Tschandl, C Rinner, Z Apalla, G Argenziano, N Codella, A Halpern, ... Nature medicine 26 (8), 1229-1234, 2020 | 1091 | 2020 |
| Bcn20000: Dermoscopic lesions in the wild M Combalia, NCF Codella, V Rotemberg, B Helba, V Vilaplana, O Reiter, ... arXiv preprint arXiv:1908.02288, 2019 | 787 | 2019 |
| A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma C Bertolotto, F Lesueur, S Giuliano, T Strub, M De Lichy, K Bille, P Dessen, ... Nature 480 (7375), 94-98, 2011 | 652 | 2011 |
| Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study P Tschandl, N Codella, BN Akay, G Argenziano, RP Braun, H Cabo, ... The lancet oncology 20 (7), 938-947, 2019 | 605 | 2019 |
| Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents AM Goldstein, M Chan, M Harland, NK Hayward, F Demenais, DT Bishop, ... Journal of medical genetics 44 (2), 99-106, 2007 | 578 | 2007 |
| Genome-wide association study identifies three loci associated with melanoma risk DT Bishop, F Demenais, MM Iles, M Harland, JC Taylor, E Corda, ... Nature genetics 41 (8), 920-925, 2009 | 573 | 2009 |
| High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL AM Goldstein, M Chan, M Harland, EM Gillanders, NK Hayward, MF Avril, ... Cancer research 66 (20), 9818-9828, 2006 | 544 | 2006 |
| A DNA methylation fingerprint of 1628 human samples AF Fernandez, Y Assenov, JI Martin-Subero, B Balint, R Siebert, ... Genome research 22 (2), 407-419, 2012 | 517 | 2012 |
| Association between immune-related adverse events and recurrence-free survival among patients with stage III melanoma randomized to receive pembrolizumab or placebo: a … AMM Eggermont, M Kicinski, CU Blank, M Mandala, GV Long, V Atkinson, ... JAMA oncology 6 (4), 519-527, 2020 | 444 | 2020 |
| Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised … AMM Eggermont, CU Blank, M Mandalà, GV Long, VG Atkinson, S Dalle, ... The lancet oncology 22 (5), 643-654, 2021 | 425 | 2021 |
| Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma KA Lee, AM Thomas, LA Bolte, JR Björk, LK de Ruijter, F Armanini, ... Nature medicine 28 (3), 535-544, 2022 | 421 | 2022 |
| Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer G Argenziano, S Puig, I Zalaudek, F Sera, R Corona, M Alsina, F Barbato, ... Journal of clinical oncology 24 (12), 1877-1882, 2006 | 397 | 2006 |
| Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy H Kittler, AA Marghoob, G Argenziano, C Carrera, C Curiel-Lewandrowski, ... Journal of the American Academy of Dermatology 74 (6), 1093-1106, 2016 | 395 | 2016 |
| Dermoscopic evaluation of amelanotic and hypomelanotic melanoma SW Menzies, J Kreusch, K Byth, MA Pizzichetta, A Marghoob, R Braun, ... Archives of dermatology 144 (9), 1120-1127, 2008 | 382 | 2008 |
| Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial AJ Stratigos, A Sekulic, K Peris, O Bechter, S Prey, M Kaatz, KD Lewis, ... The Lancet Oncology 22 (6), 848-857, 2021 | 330 | 2021 |
| Genome-wide association study identifies three new melanoma susceptibility loci JH Barrett, MM Iles, M Harland, JC Taylor, JF Aitken, PA Andresen, ... Nature genetics 43 (11), 1108-1113, 2011 | 322 | 2011 |
| Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: updated results from the EORTC 1325-MG/KEYNOTE-054 trial AMM Eggermont, CU Blank, M Mandala, GV Long, VG Atkinson, S Dalle, ... Journal of Clinical Oncology 38 (33), 3925-3936, 2020 | 319 | 2020 |
| Update in genetic susceptibility in melanoma M Potrony, C Badenas, P Aguilera, JA Puig-Butille, C Carrera, J Malvehy, ... Annals of translational medicine 3 (15), 210, 2015 | 318 | 2015 |
Joan Anton Puig Butille, PhdHead of Molecular Biology CORE laboratory, Hospital Clinic BarcelonaVerified email at clinic.cat
